Related Experiment Video
Updated: Oct 23, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
Published on: March 1, 2024
Developing a Generative Model Utilizing Self-attention Networks: Application to Materials/Drug Discovery
1Ichihara Research Laboratories, JNC Petrochemical Corporation, 5-1, Goi Kaigan, 290-8551, Ichihara, Chiba, Japan.
Abstract:
A new generative model, in which the Variational Autoencoder network is combined with the Transformer architecture, is developed. The proposed model, the Variational Autoencoding Transformer (VAT), is applied to the task of generating molecules, showing that, with proper training, the VAT model can not only produce similar molecules to input ones with high accuracy but also generate new molecules from a predefined prior almost perfectly. A desirable aspect of our VAT is that no heuristic setting is necessary for optimal performance, which suggests that the model can readily be available to a variety of datasets. As practical directions toward materials/drug discovery, two strategies: a fine-tuning method for directed molecular generation and a method of mixing molecules in the latent space, are demonstrated.
Related Concept Videos
Drug Discovery: Overview
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Drug Dependence

